BETA
BETA
Best Stocks Under $10 To Buy In 2023
paidExplore hidden gems among Stocklytics' Best Stocks Under $10 to Buy in 2023, emphasizing affordable stocks with growth potential. These picks offer opportunities for investors seeking budget-friendly options with potential for appreciation. Stocklytics focuses on stocks trading below $10 per share, indicating potential for upward movement. Whether you're a value investor or seeking opportunities at lower price points, Stocklytics' selections offer a diverse range of stocks poised for potential appreciation in the coming year.
ITIIteris | $4.90 | arrow_drop_up0.20% | $206.92M | High Growth | 40.85K | Neutralremove | - | 23.42% | AI Analysis | ||||
GASSStealthGas | $6.51 | arrow_drop_down1.66% | $244.32M | High Growth | 145.91K | Neutralremove | - | 39.99% | AI Analysis | ||||
NCMINational CineMedia | $5.71 | arrow_drop_up3.06% | $540.80M | High Growth | 309.46K | Neutralremove | - | 70.44% | AI Analysis | ||||
PRPOPrecipio | $5.54 | arrow_drop_up5.32% | $8.08M | High Growth | 17.07K | Neutralremove | - | -15.03% | AI Analysis | ||||
CTMXCytomX Therapeutics | $1.50 | arrow_drop_up5.63% | $108.30M | High Quality | 572.08K | Neutralremove | - | -13.29% | AI Analysis | ||||
CVGICommercial Vehicle Group | $5.37 | arrow_drop_down1.10% | $182.88M | High Value | 69.91K | Neutralremove | - | -48.41% | AI Analysis | ||||
MINDMind Technology | $4.76 | arrow_drop_down3.64% | $6.67M | High Growth | 607.62K | Neutralremove | - | -30.81% | AI Analysis | ||||
RAVERave Restaurant Group | $1.88 | arrow_drop_up0.53% | $27.27M | Penny Stock | 8.55K | Neutralremove | - | -15.69% | AI Analysis | ||||
HOOKHookipa Pharma | $6.15 | arrow_drop_down2.68% | $60.35M | High Growth | 11.11K | Neutralremove | - | -18.86% | AI Analysis | ||||
RMTIRockwell Medical | $1.89 | arrow_drop_up2.16% | $57.29M | High Growth | 82.90K | Neutralremove | - | -45.84% | AI Analysis | ||||
SOPASociety Pass Incorporated Common Stock | $1.51 | arrow_drop_up4.13% | $3.82M | High Growth | 372.69K | Neutralremove | - | 482.11% | AI Analysis | ||||
RCReady Capital | $9.32 | arrow_drop_up2.08% | $1.57B | High Quality | 1.05M | Neutralremove | 13.80% | -18.95% | AI Analysis | ||||
AUPHAurinia Pharmaceuticals | $5.68 | arrow_drop_up1.42% | $808.77M | - | 984.43K | Neutralremove | - | -46.66% | AI Analysis | ||||
VTSIVirTra | $8.77 | arrow_drop_up1.03% | $97.43M | Penny Stock | 86.71K | Neutralremove | - | 16.77% | AI Analysis | ||||
SRTSSensus Healthcare | $6.27 | arrow_drop_down1.10% | $101.30M | High Growth | 188.69K | Neutralremove | - | 109.00% | AI Analysis | ||||
PLXProtalix BioTherapeutics | $1.16 | arrow_drop_up0.86% | $84.34M | Penny Stock | 104.09K | Neutralremove | - | -22.14% | AI Analysis | ||||
NEPHNephros | $2.19 | arrow_drop_down0.90% | $22.66M | Penny Stock | 24.64K | Neutralremove | - | 62.22% | AI Analysis | ||||
DRCT DRCTDirect Digital Holdings | $4.16 | arrow_drop_down1.88% | $57.10M | High Growth | 43.00K | Neutralremove | - | 57.57% | AI Analysis | ||||
ZYXIZynex | $8.93 | arrow_drop_down12.36% | $283.75M | - | 1.03M | Neutralremove | - | -5.40% | AI Analysis | ||||
SPROSpero Therapeutics | $1.43 | arrow_drop_up1.41% | $76.66M | Penny Stock | 38.56K | Neutralremove | - | 1.77% | AI Analysis |
Showing 41-60 of 603
Results per page:
About Best Stocks Under $10 To Buy In 2023
Explore hidden gems among Stocklytics' Best Stocks Under $10 to Buy in 2023, emphasizing affordable stocks with growth potential. These picks offer opportunities for investors seeking budget-friendly options with potential for appreciation. Stocklytics focuses on stocks trading below $10 per share, indicating potential for upward movement. Whether you're a value investor or seeking opportunities at lower price points, Stocklytics' selections offer a diverse range of stocks poised for potential appreciation in the coming year.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.